Boston, 31 March 2026 – Bullhound Capital has participated in Whoop’s $575 million Series G at a $10.1 billion valuation, increasing its position in the human performance company. The round was led by Collaborative Fund and includes global participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures and Bullhound Capital, alongside a group of prominent global athletes and individual investors including Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, Mathieu van der Poel and Shane Lowry.
Whoop has grown from a wearable for elite athletes into a continuous health platform with more than 2.5 million members in 56 markets. Bookings grew roughly 103% year over year in 2025, exiting the year at a run rate above $1.1 billion, and the business was operating cash-flow positive for the year. The participation of Abbott and Mayo Clinic reflects the company’s expansion from fitness tracking into clinical-grade health monitoring.
The funding will advance Whoop’s global expansion across Europe, the Gulf, Latin America and Asia, broaden its healthcare and enterprise offerings, and support plans to add more than 600 roles in 2026.
Related Articles
Bullhound Capital leads Salience Labs’ $125 million Series B to scale photonic networking chips for AI datacenter infrastructure
Bullhound Capital leads Europe’s largest ever private quantum computing funding round into Oxford Quantum Circuits
Bullhound Capital invests in AI robotics pioneer Sereact in first deployment of Fund VII capital
